ライフサイエンスコーパス: chorioallantoic

1 pha or RANTES, were highly angiogenic in the chorioallantoic assay, suggesting a possible pathogenic

2 mental processes of yolk sac vasculogenesis, chorioallantoic attachment, and embryonic axis elongatio

3 The mutant mice have gross defects in chorioallantoic branching morphogenesis and placental va

4 e, while its absence in mice leads to failed chorioallantoic fusion and death at embryonic day 10.5 (

5 mozygous for the null allele fail to undergo chorioallantoic fusion and die by 10.5 days post coitus.

6 We showed that murine FGFR2 is essential for chorioallantoic fusion and placenta trophoblast cell pro

7 one third of the mutants failed to form the chorioallantoic fusion junction and the remaining mutant

8 ly returned to the tip, often colonizing the chorioallantoic fusion junction.

9 Failure of chorioallantoic fusion occurred in about two-thirds of c

10 olin, ZFP36L1, and ZFP36L2, in inflammation, chorioallantoic fusion, and early embryonic development,

11 approximately 30% succumbed to a failure in chorioallantoic fusion, and the reminder perished due to

12 The alpha4 integrin protein, required for chorioallantoic fusion, is not expressed by cells in the

13 and about 50% of them do not undergo normal chorioallantoic fusion.

14 ve beyond mid-gestation was due to defective chorioallantoic fusion.

15 ural tube defects, and die due to failure of chorioallantoic fusion.

16 to form yolk sac vasculature, and 35% failed chorioallantoic fusion.

17 pithelium, caudal dysgenesis, and failure of chorioallantoic fusion.

18 lantois, consistent with a potential role in chorioallantoic fusion.

19 ionic trophoblast (BCT) cells located at the chorioallantoic interface in murine placentas.

20 arity and basement membrane integrity at the chorioallantoic interface, as well as a severe disruptio

21 furcation (nonsprouting angiogenesis) at the chorioallantoic junction, leading to an undervasculariza

22 sing recombinant fragments of the protein on chorioallantoic membrane (CAM) angiogenesis and endothel

23 released from a polymeric implant in a chick chorioallantoic membrane (CAM) assay and laser-induced e

24 We used the chick embryo chorioallantoic membrane (CAM) assay to test the hypothe

25 An in vivo chorioallantoic membrane (CAM) assay was performed using

26 ls (HUVEC) differentiation assay and chicken chorioallantoic membrane (CAM) assay we document that st

27 is: the endothelial cell culture system, the chorioallantoic membrane (CAM) assay, and the laser-indu

28 epG2 tumor growth in a modified chick embryo chorioallantoic membrane (CAM) assay, associated with a

29 In the chick chorioallantoic membrane (CAM) assay, SsnB caused signif

30 stimulated developmental angiogenesis in the chorioallantoic membrane (CAM) assay.

31 neovascularization in the chick embryo chick chorioallantoic membrane (CAM) assay.

32 says using human vascular endothelial cells, chorioallantoic membrane (CAM) assays and xenograft tumo

33 tro and to stimulate angiogenesis ex vivo in chorioallantoic membrane (CAM) assays.

34 tested the hypothesis that the chick embryo chorioallantoic membrane (CAM) can be used as a bioreact

35 collagen onplants placed on the chick embryo chorioallantoic membrane (CAM) has been used in this stu

36 We used the chicken chorioallantoic membrane (CAM) model to determine whethe

37 Using a chicken chorioallantoic membrane (CAM) model, we demonstrated th

38 C ES-2 cell tumor growth and metastasis in a chorioallantoic membrane (CAM) model.

39 to deliver a therapeutic agent by using the chorioallantoic membrane (CAM) model.

40 lied topically on embryonic day (E) 7 to the chorioallantoic membrane (CAM) of quail embryos cultured

41 nic growth factors in onplants placed on the chorioallantoic membrane (CAM) of the chick embryos is c

42 nal, Myr-P3k, can induce angiogenesis in the chorioallantoic membrane (CAM) of the chicken embryo.

43 MD on the production of blood vessels in the chorioallantoic membrane (CAM) of the developing chicken

44 tracers, but the growth of tumors on chicken chorioallantoic membrane (CAM) provides a more rapid, lo

45 also used in vivo tumor growth on the chick chorioallantoic membrane (CAM) to observe the disseminat

46 s (HUVECs) and neovascularization in chicken chorioallantoic membrane (CAM) was examined by MTT assay

47 d in developing blood vessels of the chicken chorioallantoic membrane (CAM), a highly vascular embryo

48 injected intravenously into the chick embryo chorioallantoic membrane (CAM), and mRNA levels in the m

49 fibroblast growth factor (bFGF) on the chick chorioallantoic membrane (CAM), endothelial cell mitogen

50 and stimulated vascular growth in the chick chorioallantoic membrane (CAM).

51 vement of Na+ in either direction across the chorioallantoic membrane according to the changing deman

52 orphogenesis, and blood vessel growth in the chorioallantoic membrane and in Matrigel plug assays.

53 ood vessels in vivo as assessed by the chick chorioallantoic membrane and Matrigel plug assays.

54 elial growth factor (VEGF) function in chick chorioallantoic membrane and matrigel plug assays.

55 ntagonists inhibit angiogenesis in the chick chorioallantoic membrane and neovascularization of mouse

56 n, microtubule formation and angiogenesis in chorioallantoic membrane and nude mice models.

57 peptide were demonstrated by using the chick chorioallantoic membrane and rat corneal micropocket ass

58 ood vessels in vivo as assessed by the chick chorioallantoic membrane and the matrigel plug assays.

59 Finally, in the chicken chorioallantoic membrane angiogenesis assay, FGF-BP1 syn

60 is more potent in blocking C16-induced chick chorioallantoic membrane angiogenesis than C16S.

61 icantly impaired retinal neovascularization, chorioallantoic membrane angiogenesis, and xenograft tum

62 endothelial growth factor-dependent chicken chorioallantoic membrane angiogenic assay recapitulated

63 Chorioallantoic membrane application of follistatin (1 m

64 nd high electric field, was first applied to chorioallantoic membrane as a model system and then to r

65 rring was explored in HDFs, zebrafish, chick chorioallantoic membrane assay (CAM), and a porcine skin

66 GRO-alpha enhanced angiogenesis in the chick chorioallantoic membrane assay 2.2-fold, providing direc

67 bited angiogenesis, as analyzed by a chicken chorioallantoic membrane assay and a human umbilical vei

68 imately 3-fold decrease in tumor growth on a chorioallantoic membrane assay and approximately 2-fold

69 Using chicken chorioallantoic membrane assay and vascular endothelial

70 oblast growth factor FGF2 (97%) in a chicken chorioallantoic membrane assay at 270 nM, and peptide 40

71 inhibit angiogenesis in vivo using the chick chorioallantoic membrane assay by the inhibition of capi

72 tion potential in vivo in the chicken embryo chorioallantoic membrane assay for blood vessel penetrat

73 togenesis, and blood vessel formation in the chorioallantoic membrane assay have been found.

74 Angiogenesis induced by FGF2 in the chick chorioallantoic membrane assay was also inhibited by SCH

75 nhibited angiogenesis in vivo in the chicken chorioallantoic membrane assay, and in the Lewis lung sy

76 lary formation on Matrigel, and chick embryo chorioallantoic membrane assay, bortezomib induced a dos

77 l AngsFvs elicited angiogenesis in the chick chorioallantoic membrane assay, demonstrating that Ang i

78 binant Del1 was evaluated in an in ovo chick chorioallantoic membrane assay, it was found to have pot

79 sculitis disrupted blood flow in the chicken chorioallantoic membrane assay, suggesting an antiangiog

80 In the in vivo chick chorioallantoic membrane assay, the mouse and the trunca

81 In an in vivo chick chorioallantoic membrane assay, the PAK peptide specific

82 By using the chick chorioallantoic membrane assay, we show that HCV-infecte

83 ected in vivo angiogenesis assay and a chick chorioallantoic membrane assay, we show that Nodal promo

84 Using an ex vivo chick chorioallantoic membrane assay, we show that opticin inh

85 s was observed with GW654652 using the chick chorioallantoic membrane assay, whereas GW654652 produce

86 (rat aortic ring assay), and in vivo (chick chorioallantoic membrane assay, zebrafish, murine wild-t

87 cytotrophoblast-derived factors in the chick chorioallantoic membrane assay.

88 ophil elastase, inhibits angiogenesis in the chorioallantoic membrane assay.

89 in vitro and neovascularization in the chick chorioallantoic membrane assay.

90 okine, like vMIP-I and vMIP-II, in the chick chorioallantoic membrane assay.

91 and neuroblastoma tumour growth in the chick chorioallantoic membrane assay.

92 ntial both in vitro and in vivo in the chick chorioallantoic membrane assay.

93 al growth factor-induced angiogenesis in the chorioallantoic membrane assay.

94 om aorta rings and angiogenesis in the chick chorioallantoic membrane assay.

95 AM-1 also mediates angiogenesis in the chick chorioallantoic membrane assay.

96 cells and is angiogenic in vivo in the chick chorioallantoic membrane assay.

97 their effects on vessel formation using the chorioallantoic membrane assay.

98 dently induced vessel formation in the chick chorioallantoic membrane assay.

99 the mouse Matrigel plug assay and the chick chorioallantoic membrane assay.

100 ive in the low-pH environment of the chicken chorioallantoic membrane assay.

101 vivo angiogenesis as revealed by chicken egg chorioallantoic membrane assay.

102 and the transformed cells are tumorigenic in chorioallantoic membrane assay.

103 as H2O2-dependent as assessed by the chicken chorioallantoic membrane assay.

104 development of new veins and arteries in the chorioallantoic membrane assay.

105 ells induced angiogenesis in "in vivo" chick chorioallantoic membrane assays that could be reversed w

106 iserum in both endothelial proliferation and chorioallantoic membrane assays.

107 V-ERV infected newly formed blood vessels in chorioallantoic membrane assays.

108 giogenin-induced angiogenesis in the chicken chorioallantoic membrane at a dose as low as 20 ng per e

109 vessels, and eventually observed inside the chorioallantoic membrane capillaries, thus reflecting ea

110 The properties of chorioallantoic membrane derived from Large White Landra

111 the central cell-binding domain to the chick chorioallantoic membrane enhanced angiogenesis in an int

112 cular endothelial growth factor in the chick chorioallantoic membrane in vivo.

113 nt fibroblasts explanted atop the live chick chorioallantoic membrane lack tissue-invasive potential

114 avasation of tumor cells in an in vivo chick chorioallantoic membrane model of metastasis as well as

115 wth factor-induced angiogenesis in the chick chorioallantoic membrane model.

116 r 221*2-mediated angiogenesis in the chicken chorioallantoic membrane model.

117 angiogenesis have been studied in the chick chorioallantoic membrane model.

118 inhibits angiogenesis in Matrigel and chick chorioallantoic membrane models and also inhibits metast

119 lpha7-nAChR was confirmed in vivo by chicken chorioallantoic membrane models.

120 Xenograft Panx1-KD cells grown within the chorioallantoic membrane of avian embryos developed tumo

121 cells from the two HT-1080 variants onto the chorioallantoic membrane of chick embryos and measured l

122 ed on grafting of collagen onplants onto the chorioallantoic membrane of chick embryos.

123 y until an assay of ectodermal pocks of the chorioallantoic membrane of chicken embryos was introduc

124 of endothelial cells; (c) when placed on the chorioallantoic membrane of chicken embryos, these cells

125 s and promoted blood vessel formation in the chorioallantoic membrane of chicken embryos.

126 ox, LoVo and SW-480 tumor transplants on the chorioallantoic membrane of embryonated hen eggs showed

127 x 3c also disrupted the blood vessels in the chorioallantoic membrane of fertilized chicken eggs.

128 d in two in vivo models of angiogenesis: the chorioallantoic membrane of the chick assay and the mous

129 They induce tumors in the chorioallantoic membrane of the chicken embryo and cause

130 products in collagen onplants grafted on the chorioallantoic membrane of the chicken embryo, we demon

131 ed expression of Hox D3 in vivo on the chick chorioallantoic membrane retained EC in this invasive st

132 ure of newborn condylar cartilage on a chick chorioallantoic membrane showed that after 5 d the cells

133 Tumor growth studies on the chick chorioallantoic membrane showed that C16Y reduces breast

134 neovascularization in an experimental quail chorioallantoic membrane system and Matrigel plug format

135 On the chorioallantoic membrane the 9E3 protein is chemotactic

136 constitutively expressed Hox B3 in the chick chorioallantoic membrane using avian retroviruses that r

137 ls of tumor cell intravasation in the distal chorioallantoic membrane using quantitative human-specif

138 he primary tumor (i.e., intravasate into the chorioallantoic membrane vasculature and metastasize to

139 revented in vitro tube formation and in vivo chorioallantoic membrane vessel development.

140 g of human HT-1080 fibrosarcoma cells on the chorioallantoic membrane was used in conjunction with qu

141 PEX blocks MMP-2 activity on the chick chorioallantoic membrane where it disrupts angiogenesis

142 of zebrafish or local treatment of the chick chorioallantoic membrane with ScA resulted in dose-depen

143 etion reduced tumor development in a chicken chorioallantoic membrane xenograft model of human breast

144 y and migration assays) and in vivo (chicken chorioallantoic membrane) models and were found to exhib

145 mation, and suppresses angiogenesis in chick chorioallantoic membrane, after subcutaneous implantatio

146 It is angiogenically potent on chicken chorioallantoic membrane, but less so than angiogenin.

147 In chorioallantoic membrane, electron avalanche transfectio

148 itazone suppresses angiogenesis in the chick chorioallantoic membrane, in the avascular cornea, and i

149 rthermore, when grown in vivo in the chicken chorioallantoic membrane, primary tumors derived from Cx

150 antiangiogenic activity of HKa in the chick chorioallantoic membrane, was inhibited completely by an

151 ation and inhibits angiogenesis in the chick chorioallantoic membrane, whereas a fragment of TSP1 con

152 mediated Ras and c-Raf activity on the chick chorioallantoic membrane, whereas blockade of FAK or int

153 s on the primitive vascular bed of the chick chorioallantoic membrane, which has striking similaritie

154 wth factor-induced angiogenesis on the chick chorioallantoic membrane, with an IC50 of 10 microM.

155 ic rings and neoangiogenesis in chick embryo chorioallantoic membrane.

156 U human prostate cancer cells growing on the chorioallantoic membrane.

157 al growth factor-induced angiogenesis on the chorioallantoic membrane.

158 h factor-induced angiogenesis in the chicken chorioallantoic membrane.

159 hen applied to the rabbit cornea and chicken chorioallantoic membrane.

160 ctor-induced neovascularization of the chick chorioallantoic membrane.

161 sed avascular zones when placed on the chick chorioallantoic membrane.

162 ort hairpin RNAs from cells that invaded the chorioallantoic membrane.

163 d genes and tested for invasion of the chick chorioallantoic membrane.

164 mbly and opposes angiogenesis in the chicken chorioallantoic membrane.

165 esis assays, the frog embryo and the chicken chorioallantoic membrane.

166 12 dose-dependently enhanced angiogenesis in chorioallantoic membranes (CAMs) and HUVECs.

167 astatic tumors within 2 wk of inoculation on chorioallantoic membranes (CAMs) of chick embryos.

168 r endothelial growth factor-stimulated chick chorioallantoic membranes and basic fibroblast growth fa

169 nists specifically inhibited angiogenesis in chorioallantoic membranes and in the retina and suppress

170 Breast cancer cells implanted on chick chorioallantoic membranes and treated with CoCl(2), to m

171 It also blocked the growth of tumors on the chorioallantoic membranes of 10-day chicken embryos.

172 in could inhibit the growth of tumors on the chorioallantoic membranes of chicken embryos and in syng

173 e xenografts in a novel system that employed chorioallantoic membranes of fertilized chicken eggs as

174 lginate-g-pyrrole hydrogel system on chicken chorioallantoic membranes resulted in the formation of b

175 T-1080 fibrosarcoma cells grafted onto chick chorioallantoic membranes, which was similar to cisplati

176 ase 2 activation and angiogenesis on chicken chorioallantoic membranes.

177 ceptor) produced by trophoblast cells of the chorioallantoic placenta and acts on uterine natural kil

178 subpopulation of trophoblast cells exit the chorioallantoic placenta and enter the decidua.

179 ADA is enriched in trophoblast cells of the chorioallantoic placenta and is essential for embryonic

180 ultiple phenotypes including: defects of the chorioallantoic placenta and prenatal lethality; growth

181 Despite its importance in establishing the chorioallantoic placenta and umbilical circulation, the

182 The chorioallantoic placenta is a potential alternative targ

183 The chorioallantoic placenta is a shared derived feature of

184 trial vascular integrity, and disruptions in chorioallantoic placenta morphogenesis.

185 an enlargement of the junctional zone of the chorioallantoic placenta, a source of invasive trophobla

186 later in the labyrinthine trophoblast of the chorioallantoic placenta, where major defects are observ

187 ents to the embryo prior to development of a chorioallantoic placenta.

188 become the umbilical artery and vein of the chorioallantoic placenta.

189 coincident with the completion of the mature chorioallantoic placenta.

190 equently the labyrinthine trophoblast of the chorioallantoic placenta.

191 antois functions in the establishment of the chorioallantoic placenta.

192 her cells of the yolk sac placenta or in the chorioallantoic placenta.

193 Although chorioallantoic placentation is initiated appropriately

194 ue in large part to failures in yolk sac and chorioallantoic placentation, die around embryonic day 1